Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT05861362

Completed

Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy

Breast Cancer
NCT05110170

Completed

Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

Breast Cancer
NCT03988036

Completed

A Study With Pembrolizumab in Combination With Dual Anti-HER2 Blockade With Trastuzumab and Pertuzumab in Early Breast Cancer Patients With Molecular HER2-enriched Intrinsic Subtype (Keyriched-1) (Keyriched-1)

Breast Cancer
NCT00272987

Terminated

ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel, Trastuzumab, and Lapatinib

Neoplasms, Breast
NCT00881361

Completed

Surgery to Remove the Sentinel Lymph Node and Axillary Lymph Nodes After Chemotherapy in Treating Women With Stage II, Stage IIIA, or Stage IIIB Breast Cancer

Breast Cancer
NCT04040686

Completed

HER2 Expression Detection in Breast Cancer Using 99mTc-NM-02

Breast Cancer
NCT04745117

Completed

Health Technologies Readiness in Breast Cancer Patients

Breast Cancer
NCT05090605

Completed

The Role of Genetic Factors in the Development of Breast Cancer in the Kazakh Population

Breast Cancer
NCT00129389

Completed

FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer Patients

Breast Cancer
NCT03069742

Completed

Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting

Breast Neoplasm
NCT00129896

Completed

Neoadjuvant Chemotherapy With Myocet/Taxotere/Herceptin for HER2 Positive Breast Cancer Patients

Breast Cancer
NCT00128856

Completed

Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients

Breast Cancer
NCT04807595

Completed

Estimation of the Prevalence of HER2 Low and Describe the SoC, Treatment Patterns, and Outcome in Real-world Practice Among Unresectable and/or Metastatic Breast Cancer Patients With HER2 Low Status

Breast Cancer
NCT01497015

Completed

Memory Training Intervention for Breast Cancer Survivors

Breast Cancer
NCT03367689

Terminated

A Two-stage Simon Design Phase II Study for Non-BRCA MBC Patients With HRD Treated With Olaparib Single Agent (NOBROLA)

Breast Cancer
NCT00281658

Completed

Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2

Neoplasms, Breast
NCT05471648

Completed

A Pharmacokinetic Study Comparing EG1206A and Perjeta (Pertzumab) in Healthy Male Volunteers

Breast Cancer
NCT02400658

Active, not recruiting

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

Breast Cancer
NCT04689945

Completed

Metabolomic Profiling of Erector Spinae Plane Block* for Breast Cancer Surgery (ESP)

Breast Cancer
NCT02305641

Completed

An Observational Study of Kadcyla Safety in Breast Cancer

Breast Cancer
NCT00773695

Completed

A Study of Bevacizumab (Avastin) in Combination With Neoadjuvant Treatment Regimens in Participants With Primary Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast Cancer

Breast Cancer
NCT04262219

Completed

Clinician Communication About Sexual Health

Breast Cancer
NCT04132817

Completed

A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Has Spread

Breast Cancer
NCT03344536

Completed

A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

Breast Cancer
NCT00433589

Completed

Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes (MINDACT)

Breast Cancer
NCT05615298

Completed

Study to Evaluate Effectiveness of Investigational Device in the Assistance of Detection and Diagnosis of Breast Cancer

Breast Cancer
NCT05600257

Completed

The Effect of Digital Breast Tomosynthesis in Breast Cancer Long-term Survival: a Single Institution Study

Breast Cancer
NCT04781062

Active, not recruiting

Development of a Horizontal Data Integration Classifier for Noninvasive Early Diagnosis of Breast Cancer (RENOVATE)

Breast Cancer
NCT02019303

Completed

Accuracy of FNA Versus CNB of Abnormal Axillary Lymph Nodes in Setting of Invasive Breast Cancer

Breast Cancer
NCT02725658

Withdrawn

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using DOSI

Breast Tumor
NCT01277263

Withdrawn

Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic Imaging

Breast Cancer
NCT01257932

Withdrawn

Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging

Breast Cancer
NCT04781712

Completed

Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer (MMHTR)

Breast Cancer
NCT04460430

Terminated

Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer (NEREA)

Breast Cancer
NCT01646034

Active, not recruiting

High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer (Oligo)

Breast Cancer
NCT03992521

Active, not recruiting

Breast Cancer Liquid Biopsy Stratification (BALIBISTRA)

Breast Cancer
NCT04267900

Completed

99mTc-HPArk2 SPECT/CT for the Detection of HER2-positive Breast Cancer

Breast Cancer
NCT05047575

Completed

Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals (REASSURE)

Breast Cancer
NCT01791985

Completed

AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL) (RADICAL)

Breast Cancer
NCT02514837

Withdrawn

Microwave Radiometry for the Diagnosis and Monitoring of Breast Cancer (RTM)

Breast Cancer
NCT00754598

Completed

Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography

Breast Cancer
NCT04874025

Completed

Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer (PALBOSPAIN)

Breast Cancer
NCT03990012

Completed

Infrared Imaging for Breast Cancer Modeling

Breast Cancer
NCT04176757

Completed

A Study of ZN-c5 in Participants With Breast Cancer

Breast Cancer
NCT04850625

Completed

Pyrotinib Plus Vinorelbine Versus Lapatinib Plus Capecitabine

Breast Cancer
NCT02562612

Withdrawn

Study of SM-88 in Advanced Cancers

Breast Cancer
NCT02803593

Completed

To Enhance Breast Cancer Survivorship of Asian Americans (TICAA)

Breast Cancer
NCT00754312

Terminated

A Phase I, Multicenter, Open Label Study on the Effects of SNDX-275 on Expression of Biomarkers in Subjects With Newly Diagnosed Breast Cancer

Breast Cancer
NCT02651844

Completed

Mifepristone for Breast Cancer Patients With Higher Levels of Progesterone Receptor Isoform A Than Isoform B. (MIPRA)

Breast Cancer
NCT05359874

Withdrawn

Improvement of the Operative Outcome in Patients With Primary VEGF + Unifocal Breast Cancer or DCIS Through the Intraoperative Visualization of the Tumor Using Molecular Imaging and Bevacizumab-IRDye-800CW (DoT-FMI)

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations